| Financial Year |
March 31 2023 |
| Monetary Funds |
513,312,511.19 |
| Held-for-trading Financial Assets |
500,000,000.00 |
| Notes Receivable |
72,824.17 |
| Accounts Receivable |
51,302,366.47 |
| Advances to Suppliers |
30,142,584.63 |
| Other Receivables |
1,154,365.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
96,659,961.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,621,189.12 |
| Total Current Assets |
1,196,265,801.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
331,780,137.34 |
| Under-construction Projects |
204,460,438.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,507,943.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,544,077.49 |
| Deferred Income Tax Assets |
35,366,011.73 |
| Other Non-Current Assets |
4,514,546.07 |
| Sub-Total of Non-Current Assets |
682,191,779.34 |
| Total Assets |
1,878,457,581.27 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
111,422,431.45 |
| Accounts Payable |
185,328,948.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,936,719.21 |
| Taxes Payable |
30,435,067.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
57,022,440.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,366,115.75 |
| Other Current Liabilities |
1,219,008.73 |
| Sub-Total of Current Liabilities |
448,602,112.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,410,634.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
45,343,356.87 |
| Total Liabilities |
493,945,469.13 |
| Paid-In Capital(Or Share Stock) |
107,398,200.00 |
| Capital Surplus |
677,484,763.92 |
| Surplus Reserve |
54,046,600.00 |
| LESS:Treasury Stock |
19,097,058.89 |
| Undistributed Profits |
545,352,676.79 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,384,512,112.14 |
| Owner's Equity（Stockholder's Equity） |
1,384,512,112.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,878,457,581.27 |
